SP716 Study Group; SP715 Study Group. Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER - LeWitt, PA; Boroojerdi, B; Surmann, E; Poewe, W (J Neural Transm, 2013)